Literature DB >> 16650477

Modelling calcium carbonate biomineralisation processes.

Saratchandra Babu Mukkamala1, Christopher E Anson, Annie K Powell.   

Abstract

The structure-directing influence of the organic dicarboxylates malonate, succinate, glutarate and adipate as templating species on the hydrothermal formation of CaCO(3) was investigated at different temperatures (60, 80, 90, 120, 150 and 190 degrees C) and with a range of molar ratios of [Ca(2+)]/[templating species] (20, 14.3, 10, 7.7, 5, 1, 0.5 and 0.33). In the presence of the dicarboxylates, one, two or three polymorphs of CaCO(3) - calcite, aragonite and vaterite - could be formed, depending on the reaction conditions. In addition changes in crystal morphology were observed for the CaCO(3) polymorphs depending on the concentration of the template. In contrast, synthesis under ambient conditions of temperature and pressure resulted only in calcite formation, although template-dependent morphological changes were again observed. Crystalline products were all characterized by powder X-ray patterns and SEM (Scanning Electron Microscopy) micrographs. The ambient reactions with the chelating, dinucleating carboxylato ligands H(3)heidi and H(5)hpdta produce more profound changes in calcite morphology. With H(3)heidi rounded calcite crystals with shapes similar to that of otoliths are formed and with H(5)hpdta the formation of microtrumpets of constructed from bundles of nanocrystals of calcite is observed. The possible mode of action of these ligands on calcite formation is discussed in the context of known coordination chemistry with other metal ions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650477     DOI: 10.1016/j.jinorgbio.2006.02.012

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  1 in total

1.  Nanoscale analysis of the morphology and surface stability of calcium carbonate polymorphs.

Authors:  W Sekkal; A Zaoui
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.